rs138955932

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_005506.4(SCARB2):​c.194A>T​(p.Tyr65Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,522 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y65C) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

SCARB2
NM_005506.4 missense

Scores

1
8
10

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 5.83

Publications

3 publications found
Variant links:
Genes affected
SCARB2 (HGNC:1665): (scavenger receptor class B member 2) The protein encoded by this gene is a type III glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes. Earlier studies in mice and rat suggested that this protein may participate in membrane transportation and the reorganization of endosomal/lysosomal compartment. The protein deficiency in mice was reported to impair cell membrane transport processes and cause pelvic junction obstruction, deafness, and peripheral neuropathy. Further studies in human showed that this protein is a ubiquitously expressed protein and that it is involved in the pathogenesis of HFMD (hand, foot, and mouth disease) caused by enterovirus-71 and possibly by coxsackievirus A16. Mutations in this gene caused an autosomal recessive progressive myoclonic epilepsy-4 (EPM4), also known as action myoclonus-renal failure syndrome (AMRF). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
SCARB2 Gene-Disease associations (from GenCC):
  • action myoclonus-renal failure syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • progressive myoclonus epilepsy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Unverricht-Lundborg syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.766

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCARB2NM_005506.4 linkc.194A>T p.Tyr65Phe missense_variant Exon 2 of 12 ENST00000264896.8 NP_005497.1 Q14108-1A0A024RDG6
SCARB2NM_001204255.2 linkc.194A>T p.Tyr65Phe missense_variant Exon 2 of 9 NP_001191184.1 Q14108-2
SCARB2XM_047416429.1 linkc.-281A>T 5_prime_UTR_variant Exon 2 of 12 XP_047272385.1
SCARB2XM_047416430.1 linkc.-281A>T 5_prime_UTR_variant Exon 2 of 12 XP_047272386.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCARB2ENST00000264896.8 linkc.194A>T p.Tyr65Phe missense_variant Exon 2 of 12 1 NM_005506.4 ENSP00000264896.2 Q14108-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000398
AC:
1
AN:
251420
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461522
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
727098
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33474
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111686
Other (OTH)
AF:
0.00
AC:
0
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.00000824
AC:
1

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.052
T
BayesDel_noAF
Benign
-0.14
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Uncertain
0.58
D;.;.;.;.;.;.
Eigen
Benign
-0.019
Eigen_PC
Benign
0.065
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.96
D;D;D;D;D;D;D
M_CAP
Benign
0.054
D
MetaRNN
Pathogenic
0.77
D;D;D;D;D;D;D
MetaSVM
Uncertain
0.20
D
MutationAssessor
Uncertain
2.1
M;.;.;.;.;M;.
PhyloP100
5.8
PrimateAI
Uncertain
0.54
T
PROVEAN
Uncertain
-2.7
D;.;.;.;.;N;.
REVEL
Uncertain
0.51
Sift
Benign
0.27
T;.;.;.;.;T;.
Sift4G
Benign
0.13
T;.;.;.;.;T;.
Polyphen
0.54
P;.;.;.;.;.;.
Vest4
0.61
MutPred
0.82
Gain of glycosylation at T62 (P = 0.0262);Gain of glycosylation at T62 (P = 0.0262);Gain of glycosylation at T62 (P = 0.0262);Gain of glycosylation at T62 (P = 0.0262);Gain of glycosylation at T62 (P = 0.0262);Gain of glycosylation at T62 (P = 0.0262);Gain of glycosylation at T62 (P = 0.0262);
MVP
0.54
MPC
0.49
ClinPred
0.94
D
GERP RS
4.3
Varity_R
0.70
gMVP
0.56
Mutation Taster
=44/56
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138955932; hg19: chr4-77116941; API